How tumor-specific modulation frequencies were discovered

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In the spring of 2001, I visited a longtime friend and collaborator, Alexandre Barbault, to share with him my vision of using low levels radiofrequency electromagnetic fields for the treatment of cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Boris C. Pasche
Charles L. Spurr Professor of Medicine, Chairman, Department of Cancer Biology; Director, Comprehensive Cancer Center of Wake Forest University

YOU MAY BE INTERESTED IN

Congress settled the FY26 question in February, with NCI receiving $7.352 billion, an increase of $128 million over the prior year. After a year in which cancer center directors spent an extraordinary share of their leadership attention defending the research enterprise, that outcome deserves to be called what it was: a win.
Harold P. Freeman, a surgeon who started his career in Harlem, where, in addition to performing surgeries, he pioneered the system of patient navigation, and who studied health disparities and served as president of the American Cancer Society and chair of the President’s Cancer Panel, died on Aug. 11. He was 93.
Boris C. Pasche
Charles L. Spurr Professor of Medicine, Chairman, Department of Cancer Biology; Director, Comprehensive Cancer Center of Wake Forest University

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login